Capital Performance Advisors LLP Adma Biologics, Inc. Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Capital Performance Advisors LLP holds 949 shares of ADMA stock, worth $19,084. This represents 0.01% of its overall portfolio holdings.
Number of Shares
949Holding current value
$19,084% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
185MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$375 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$364 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$262 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$254 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$173 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.95B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...